HALOETTE

searchlight pharma inc🇨🇦 Health Canada

Approval Id: e93c0531438ab471
Drug Approval Canada Name: HALOETTE
Product Name: HALOETTE
Status: Marketed
Status Date: 2021-09-29
Original Market Date: 2021-09-29
Din: 02520028
Drug Class: Human
Dosage Form: Ring (Slow-Release)
Route Of Administration: Vaginal
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN
Atc Name: g 02 bb 01
Aig Number: 0250087001
Company Name: searchlight pharma inc
Company Address: 1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1

ETONOGESTREL

11.7 MG

ETHINYL ESTRADIOL

2.7 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e93c0531438ab471

Type

Standard